CYABRA (CYAB) Chief Product Officer Daar Yossef Acquires Shares & Warrants

What Happened

• Daar Yossef, Chief Product Officer and a director of CYABRA, purchased 53,650 common shares from the issuer and also purchased two separate warrant tranches in a private placement on July 10, 2026. The common-stock purchase was for roughly $23,338; the two warrant purchases cost about $24,143 and $26,825 respectively, for a combined cash outlay of approximately $74,306. These were purchases (cash paid to the company), not sales.

Key Details

• Transaction date: July 10, 2026 (reported on Form 4 filed July 13, 2026 — appears timely).
• Common stock: 53,650 shares purchased from the issuer at $0.435/share ($23,338).
• Series B warrant purchase: rights to buy up to 53,650 shares, paid $0.45/share ($24,143).
• Series A warrant purchase: rights to buy up to 53,650 shares, paid $0.50/share ($26,825).
• Shares owned after transaction: not specified in the provided filing.
• Notable footnotes: (1) common shares and warrants were acquired in a private placement; (2) both Series A and B warrants become exercisable only upon receipt of requisite stockholder approval; (3) Series B warrants expire 12 months after the initial exercise date; (4) Series A warrants expire five years after the initial exercise date.

Context

• The two P-coded derivative entries are purchases of warrants (rights to buy common stock later), not exercises of options — they do not create new shares until (and unless) the warrants are exercised. Because exercisability depends on stockholder approval and the Series B warrant has a short effective life after exercise, the timing and dilutive impact depend on future approvals and actions. Insider purchases in private placements show a direct cash investment in the company but do not by themselves prove future performance.